OLEG I. KIT

OLEG I. KIT

Principal occupation: General Director of the Federal State Budgetary Institution "NMIC of Oncology" of the Ministry of Health of the Russian Federation (Rostov-on-Don).

Academic degree, title: Doctor of Sci. (Med.), Professor, Academician of the Russian Academy of Sciences.

Scientific speciality: 3.1.6. Oncology, radiation oncology.

Publications: 1,366 research papers, 10 textbooks, 17 monographs, 209 patents.

Professional memberships:

  • Russian Association of Surgeons;
  • Association of Oncologists of Russia;
  • Association for Directors of Institutes of Oncology and Radiology, CIS & Eurasia (ADIOR );
  • American Society of Clinical Oncology, European Society for Medical Oncology (ESMO);
  • Member of the Dissertation Council of the Federal State Budgetary Institution "NMIC of Oncology" of the Ministry of Health of Russia.

Journal editorial board membership:

  • Editor-in-chief of South Russian Journal of Cancer (ISSN 2686-9039 Online),
  • Member of the editorial board of the following journals:
    • Oncology Bulletin of the Volga Region (ISSN 2078-1466);
    • P.A. Herzen Journal of Oncology (ISSN 2309-4745; 2305-218X);
    • Eurasian Journal of Oncology (ISSN 2414-2360; 2309-7485);
    • Voprosy Onkologii (ISSN 0507–3758);
    • Pediatric Hematology/Oncology and Immunopathology (ISSN 1726-1708 (Print); ISSN 2414-9314 (Online));
    • Russian Journal of Oncology (ISSN: 1028-9984 (Print); 2412-9119 (Online)).

Area of expertise: Development of organ-preserving, reconstructive, and minimally invasive surgeries for tumor diseases; use of modern vascular surgery technologies in the treatment of gastrointestinal cancers; photodynamic therapy for esophageal and gastric cancer; interventional radiological (X-ray endovascular) interventions for liver cancer; prevention of postoperative complications; study of molecular-genetic and pathophysiological mechanisms of malignant tumors; development of an organizational model for timely and early diagnosis of malignant tumors of various localizations; cell-based immunotherapy and preclinical trials on humanized and genetically modified animals; development of new targeted drugs and biomarkers for early diagnosis and screening of cancer.

eLibrary SPIN: 1728-0329
ORCID: 0000-0003-3061-6108
Scopus: 55994103100
ResearcherID: U-2241-2017
PubMed: Kit OI